Lapatinib + Midazolam Interaction
Unknowninteraction on record
Description
Midazolam : Following coadministration of lapatinib and midazolam (CYP3A4 substrate), 24-hour systemic exposure (AUC) of orally administered midazolam increased 45%, while 24-hour AUC of intravenously administered midazolam increased 22%.
Source: FDA drug label - lapatinib